11-1951017-A-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_021134.4(MRPL23):c.136A>T(p.Met46Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021134.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL23 | NM_021134.4 | c.136A>T | p.Met46Leu | missense_variant | Exon 2 of 5 | ENST00000397298.8 | NP_066957.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 6
GnomAD4 exome Cov.: 0
GnomAD4 genome Cov.: 6
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.136A>T (p.M46L) alteration is located in exon 2 (coding exon 2) of the MRPL23 gene. This alteration results from a A to T substitution at nucleotide position 136, causing the methionine (M) at amino acid position 46 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at